<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03939260</url>
  </required_header>
  <id_info>
    <org_study_id>13175/2019</org_study_id>
    <nct_id>NCT03939260</nct_id>
  </id_info>
  <brief_title>ECCO2R - Mechanical Power Study</brief_title>
  <official_title>The Effects of Low Flow Extracorporeal CO2 Removal on Mechanical Power in ARDS Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Milan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Milan</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although mechanical ventilation remains the cornerstone of ARDS treatment, several
      experimental and clinical studies have undoubtedly demonstrated that it can contribute to
      high mortality through the developing of ventilator induced lung injury even in patients with
      plateau pressure &lt;30 cmH2O. Since now there are no studies exploring the application of low
      flow extracorporeal CO2 removal and ultraprotective ventilation to reduce mechanical power, a
      composite index of VILI, independently from the value of plateau pressure or the severity of
      hypercapnia.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 20, 2019</start_date>
  <completion_date type="Anticipated">March 2024</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mechanical Power reduction.</measure>
    <time_frame>Changes from baseline to day 5.</time_frame>
    <description>Achievement of Mechanical Power reduction under 18 J/min while maintaining pH and PaCO2 to Â± 20% of baseline values obtained at tidal volume of 6 mL/kg.
Mechanical Power (MP) (J/min) = 0.098 * respiratory rate * tidal volume (inspiratory peak airway pressure - 1/2 * (airway pressure at end inspiratory pause - airway pressure at PEEP))</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Respiratory mechanics.</measure>
    <time_frame>Every six hours, every day until the fifth day or until the weaning from ECCO2R if lower than five days</time_frame>
    <description>1. Respiratory system elastance (Ers) (cmH2O/L) = (airway pressure at end inspiratory pause - airway pressure at PEEP) / tidal volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory mechanics.</measure>
    <time_frame>Every six hours, every day until the fifth day or until the weaning from ECCO2R if lower than five days</time_frame>
    <description>2. Lung elastance (El) (cmH2O/L) = (transpulmonary pressure at end inspiratory pause - transpulmonary pressure at PEEP / tidal volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory mechanics.</measure>
    <time_frame>Every six hours, every day until the fifth day or until the weaning from ECCO2R if lower than five days</time_frame>
    <description>3. Chest wall elastance (Ecw) (cmH2O/L) = (esophageal pressure at end inspiratory pause - esophageal pressure at PEEP) / tidal volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory mechanics.</measure>
    <time_frame>Every six hours, every day until the fifth day or until the weaning from ECCO2R if lower than five days</time_frame>
    <description>4. End inspiratory transpulmonary pressure (cmH2O)= airway pressure at end inspiratory pause - (esophageal pressure at end inspiratory pause - expiration at atmospheric pressure by a release manouvre).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gas exchange.</measure>
    <time_frame>Every six hours, every day until the fifth day or until the weaning from ECCO2R if lower than five days</time_frame>
    <description>Assessment of changes in PaCO2 mmHg.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gas exchange.</measure>
    <time_frame>Every six hours, every day until the fifth day or until the weaning from ECCO2R if lower than five days</time_frame>
    <description>Assessment of changes in PaO2 mmHg.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gas exchange.</measure>
    <time_frame>Every six hours, every day until the fifth day or until the weaning from ECCO2R if lower than five days</time_frame>
    <description>Assessment of changes in PaO2/FiO2.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety assessment and adverse device related events: frequency of serious adverse events</measure>
    <time_frame>Every day, until the fifth day or until the weaning from ECCO2R if lower than five days</time_frame>
    <description>Safety assessment reporting frequency of serious adverse events in terms of device related mechanical events (Pump malfunction, membrane lung clotting, system leaks, tubing rupture, air in the circuit) and device related clinical events (heamolysis, significant bleeding, thromboembolic complications, neurologic complications, metabolic complications).</description>
  </secondary_outcome>
  <enrollment type="Anticipated">15</enrollment>
  <condition>ARDS, Human</condition>
  <condition>Extracorporeal CO2 Removal</condition>
  <condition>Mechanical Power</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Extracorporeal CO2 Removal</intervention_name>
    <description>Extracorporeal carbon dioxide removal (ECCO2R), a low flow extracorporeal CO2 removal, may be used in association with ultraprotective mechanical ventilation (tidal volume &lt; 6 ml/kg and Pplat &lt;20-25 cmH2O).</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult respiratory distress syndrome (ARDS) patients, affected by a life-threatening
        condition characterized by nonhydrostatic pulmonary edema that can be caused by pulmonary
        (eg, pneumonia, aspiration) or nonpulmonary (eg, sepsis, pancreatitis, trauma) insults and
        accounts for 10% of intensive care unit (ICU) admissions. Mortality remains high ranging
        from 35% to 46% and it has been estimated that at least 150,000 individuals die each year
        of adult respiratory distress syndrome.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        ARDS patients undergoing mechanical ventilation with:

          -  PaO2/FiO2 &lt;150 with a level of positive end expiratory pressure (PEEP) of 10 cmH2O or
             higher with a FiO2 &gt; 0.5

          -  Plateau pressure of 28 cmH2O or higher with tidal volume of 6 ml/Kg of ideal body
             weight

          -  Mechanical power of 18 J/min or higher.

        Exclusion Criteria:

          -  &lt;18 years of age

          -  Pregnancy

          -  Obesity with BMI&gt; 30

          -  Platelets &lt;30 G/l

          -  Decompensated heart failure or acute coronary syndrome

          -  Acute brain injury

          -  Contraindication for systemic anticoagulation (for example, gastrointestinal bleeding,
             recent cerebrovascular accident, or chronic bleeding disorder, recent major surgery)

          -  Patient moribund, decision to limit therapeutic interventions

          -  Catheter access to femoral vein or jugular vein impossible

          -  Pneumothorax.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Davide Chiumello, Professor</last_name>
    <phone>+390281844020</phone>
    <email>chiumello@libero.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>ASST-Santi Paolo e Carlo, San Paolo Hospital</name>
      <address>
        <city>Milan</city>
        <zip>20142</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Davide Chiumello</last_name>
      <phone>+390281844020</phone>
      <email>chiumello@libero.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, Ranieri M, Rubenfeld G, Thompson BT, Wrigge H, Slutsky AS, Pesenti A; LUNG SAFE Investigators; ESICM Trials Group. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016 Feb 23;315(8):788-800. doi: 10.1001/jama.2016.0291. Erratum in: JAMA. 2016 Jul 19;316(3):350. JAMA. 2016 Jul 19;316(3):350.</citation>
    <PMID>26903337</PMID>
  </reference>
  <reference>
    <citation>Fan E, Needham DM, Stewart TE. Ventilatory management of acute lung injury and acute respiratory distress syndrome. JAMA. 2005 Dec 14;294(22):2889-96. Review.</citation>
    <PMID>16352797</PMID>
  </reference>
  <reference>
    <citation>Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000 May 4;342(18):1301-8.</citation>
    <PMID>10793162</PMID>
  </reference>
  <reference>
    <citation>Chiumello D, Brochard L, Marini JJ, Slutsky AS, Mancebo J, Ranieri VM, Thompson BT, Papazian L, Schultz MJ, Amato M, Gattinoni L, Mercat A, Pesenti A, Talmor D, Vincent JL. Respiratory support in patients with acute respiratory distress syndrome: an expert opinion. Crit Care. 2017 Sep 12;21(1):240. doi: 10.1186/s13054-017-1820-0. Review.</citation>
    <PMID>28899408</PMID>
  </reference>
  <reference>
    <citation>Gattinoni L, Tonetti T, Cressoni M, Cadringher P, Herrmann P, Moerer O, Protti A, Gotti M, Chiurazzi C, Carlesso E, Chiumello D, Quintel M. Ventilator-related causes of lung injury: the mechanical power. Intensive Care Med. 2016 Oct;42(10):1567-1575. doi: 10.1007/s00134-016-4505-2. Epub 2016 Sep 12.</citation>
    <PMID>27620287</PMID>
  </reference>
  <reference>
    <citation>Cressoni M, Gotti M, Chiurazzi C, Massari D, Algieri I, Amini M, Cammaroto A, Brioni M, Montaruli C, Nikolla K, Guanziroli M, Dondossola D, Gatti S, Valerio V, Vergani GL, Pugni P, Cadringher P, Gagliano N, Gattinoni L. Mechanical Power and Development of Ventilator-induced Lung Injury. Anesthesiology. 2016 May;124(5):1100-8. doi: 10.1097/ALN.0000000000001056.</citation>
    <PMID>26872367</PMID>
  </reference>
  <reference>
    <citation>Kolobow T, Gattinoni L, Tomlinson T, Pierce JE. An alternative to breathing. J Thorac Cardiovasc Surg. 1978 Feb;75(2):261-6.</citation>
    <PMID>625133</PMID>
  </reference>
  <reference>
    <citation>Peek GJ, Clemens F, Elbourne D, Firmin R, Hardy P, Hibbert C, Killer H, Mugford M, Thalanany M, Tiruvoipati R, Truesdale A, Wilson A. CESAR: conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure. BMC Health Serv Res. 2006 Dec 23;6:163.</citation>
    <PMID>17187683</PMID>
  </reference>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>April 16, 2019</study_first_submitted>
  <study_first_submitted_qc>May 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 6, 2019</study_first_posted>
  <last_update_submitted>May 3, 2019</last_update_submitted>
  <last_update_submitted_qc>May 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Milan</investigator_affiliation>
    <investigator_full_name>Davide Chiumello</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

